Ocular Surface Disease Index (OSDI): A potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials?

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 812-813

  Gabbriellini, G ^a   Baldini, C ^a   Varanini, V ^a   Ferro, F ^a   Pepe, P ^a   Luciano, N ^a   Fanucci, F ^a   Mosca, M ^a   Nardi, M ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DISEASE DURATION; DRY EYE; FATIGUE; FEMALE; HUMAN; LETTER; MALE; OCULAR SURFACE DISEASE INDEX; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCHIRMER TEST; SJOEGREN SYNDROME; SYMPTOMATOLOGY; VISION TARGETED HEALTH RELATED QUALITY OF LIFE; VISUAL ANALOG SCALE; XEROSTOMIA;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS AS TOPIC; DRY EYE SYNDROMES; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TREATMENT OUTCOME; VISION, OCULAR;

EID: 84870271559     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. BALDINI C, PEPE P, LUCIANO N et al:. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome. J Rheumatol 2012;39:804-8.
2. ALBRECHT J, ATZENI F, BALDINI C et al:. Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 2006;24:S52-9.
3. BALDINI C, TALARICO R, TZIOUFAS AG, BOMBARDIERI S: Classification criteria for Sjögren's syndrome: A critical review. J Autoimmun 2012;39:9-14.
4. VERSURA P, FRIGATO M, CELLINI M, MULE R, MALAVOLTA N, CAMPOS EC: Diagnostic performance of tear function tests in Sjögren's syndrome patients. Eye (London) 2007;21:229-37.
5. GUILLEMIN I, BEGLEY C, CHALMERS R, BAUDOUIN C, ARNOULD B: Appraisal of patientreported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf 2012;10:84-99.
6. SEROR R, BOOTSMA H, BOWMAN SJ et al.: Outcome measures for primary Sjögren's syndrome. J Autoimmun 2012;39:97-102.
7. BALDINI C, GIUSTI L, CIREGIA F et al: Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther 2011;13:R194.
8. BALDINI C, GIUSTI L, BAZZICHI L, LUCACCHINI A, BOMBARDIERI S; Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? Autoimmun Rev 2008;7:185-91.
9. GIUSTI L, BALDINI C, BAZZICHI L, BOMBARDIERI S, LUCACCHINI A: Proteomic diagnosis of Sjögren's syndrome. Expert Rev Proteomics 2007;4:757-67.
10. GALLO A, BALDINI C, TEOS L, MOSCA M, BOMBARDIERI S, ALEVIZOS I: Emerging trends in Sjögren's syndrome: basic and translational research. Clin Exp Rheumatol 2012 Sep. 25 [Epub ahead of print].
11. BALDINI C, GALLO A, PEREZ P, MOSCA M, ALEVIZOS I, BOMBARDIERI S: Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. Clin Exp Rheumatol 2012 Sep. 25 [Epub ahead of print].
12. DOUGHERTY BE, NICHOLS JJ, NICHOLS KK: Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest Ophthalmol Vis Sci 2011;52:8630-5.
13. LI M, GONG L, CHAPIN WJ, ZHU M: Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci 2012;53:5722-7.
14. SEROR R, RAVAUD P, BOWMAN SJ et al.: EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-9.
15. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.